DK1078627T3 - Farmaceutisk præparat omfattende amoxillin og clavulanat - Google Patents

Farmaceutisk præparat omfattende amoxillin og clavulanat

Info

Publication number
DK1078627T3
DK1078627T3 DK00202882T DK00202882T DK1078627T3 DK 1078627 T3 DK1078627 T3 DK 1078627T3 DK 00202882 T DK00202882 T DK 00202882T DK 00202882 T DK00202882 T DK 00202882T DK 1078627 T3 DK1078627 T3 DK 1078627T3
Authority
DK
Denmark
Prior art keywords
clavulanate
amoxillin
flavour
pharmaceutical composition
extra
Prior art date
Application number
DK00202882T
Other languages
English (en)
Inventor
Nathalie Barges
Jacky Andre Gustave Mention
Original Assignee
Glaxosmithkline Lab Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9919840.0A external-priority patent/GB9919840D0/en
Priority claimed from GBGB9920150.1A external-priority patent/GB9920150D0/en
Priority claimed from GB0019084A external-priority patent/GB0019084D0/en
Application filed by Glaxosmithkline Lab Sas filed Critical Glaxosmithkline Lab Sas
Application granted granted Critical
Publication of DK1078627T3 publication Critical patent/DK1078627T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK00202882T 1999-08-20 2000-08-17 Farmaceutisk præparat omfattende amoxillin og clavulanat DK1078627T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9919840.0A GB9919840D0 (en) 1999-08-20 1999-08-20 Pharmaceutical formulation
GBGB9920150.1A GB9920150D0 (en) 1999-08-25 1999-08-25 Pharmaceuticals formulation
GB0019084A GB0019084D0 (en) 2000-08-03 2000-08-03 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
DK1078627T3 true DK1078627T3 (da) 2006-11-13

Family

ID=27255829

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00202882T DK1078627T3 (da) 1999-08-20 2000-08-17 Farmaceutisk præparat omfattende amoxillin og clavulanat

Country Status (9)

Country Link
US (1) US6977086B1 (da)
EP (1) EP1078627B1 (da)
AT (1) ATE334655T1 (da)
AU (1) AU6571400A (da)
DE (1) DE60029698T2 (da)
DK (1) DK1078627T3 (da)
ES (1) ES2269063T3 (da)
PT (1) PT1078627E (da)
WO (1) WO2001013883A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
CA2529102A1 (en) * 2003-06-16 2004-12-23 Glaxo Group Limited Pharmaceutical formulations comprising amoxicillin and clavulanate
GB0313913D0 (en) * 2003-06-16 2003-07-23 Beecham Pharm Pte Ltd New use
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CN103349659A (zh) * 2006-09-26 2013-10-16 塔罗制药北美有限公司 液体药物组合物以及应用
CN101406450B (zh) * 2007-10-12 2010-08-25 河南农业大学 复方阿莫西林油混悬注射液制备工艺
WO2010132662A1 (en) * 2009-05-13 2010-11-18 Relypsa, Inc. Powder formulations of potassium-binding active agents
KR101486999B1 (ko) * 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101178217B1 (ko) * 2009-10-28 2012-09-07 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
TWI463998B (zh) * 2009-12-31 2014-12-11 Synmosa Biopharma Corp Amoxicillin and clomycin have a high absorption rate of pharmaceutical ingredients
CN114668724B (zh) * 2020-12-24 2023-08-22 鲁南制药集团股份有限公司 一种阿莫西林克拉维酸钾干混悬剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114929A (en) 1989-03-21 1992-05-19 Beecham Group P.L.C. Pharmaceutical formulation
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
ES2201468T3 (es) * 1997-02-14 2004-03-16 Laboratoire Glaxosmithkline S.A.S. Preparacion farmaceutica que comprende amoxicilina y clavulanato.
GB9815532D0 (en) 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation

Also Published As

Publication number Publication date
WO2001013883A1 (en) 2001-03-01
PT1078627E (pt) 2006-10-31
EP1078627A1 (en) 2001-02-28
ES2269063T3 (es) 2007-04-01
EP1078627B1 (en) 2006-08-02
AU6571400A (en) 2001-03-19
US6977086B1 (en) 2005-12-20
DE60029698T2 (de) 2007-08-02
DE60029698D1 (de) 2006-09-14
ATE334655T1 (de) 2006-08-15

Similar Documents

Publication Publication Date Title
NO2016005I1 (no) 2-okso-1-pyrrolidinderivater, farmasøytisk preparat og deres anvendelse for fremstilling av et medikament
DK1078627T3 (da) Farmaceutisk præparat omfattende amoxillin og clavulanat
BE2011C028I2 (en) Macrocyclic analogs and methods of their use and preparation
AP1253A (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate.
WO2003002136A3 (en) Stable formulation of modified glp-1
ATE251133T1 (de) Neue strukturelle vitamin d derivate
HK1034183A1 (en) Galenic formulations of meloxicam for oral administration.
IL157963A0 (en) Hsa-free formulations of interferon-beta
ATE334663T1 (de) Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe
WO2001005355A3 (en) Formulations for il-11
LU91882I2 (fr) Pradofloxacin et ses dérivés pharmaceutiquement acceptables (VERAFLOX®)
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
IL160051A0 (en) Ecteinascidin derivatives and pharmaceutical compositions containing the same
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
ATE301986T1 (de) Kosmetische stiftzubereitung
IL148874A0 (en) Sulfonyl amino acid derivatives, their preparation and pharmaceutical compositions containing them
EP1057472A4 (en) SOLID PREPARATION FOR ORAL HYGIENE
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
EE200100596A (et) Ülipuhas (1R,2S,4R)-(-)-2-[(2'-{N,N-dimetüülamino}etoksü)]-2-[fenüül]-1,7,7-tri[metüül]bitsüklo[2.2.1 ]heptaan ja selle farmatseutiliselt vastuvõetavad happeliitsoolad ning nimetatud ühendite, samutiravimite, mis sisaldavad üks või enam nimetatud üh
GEP20043377B (en) Pharmaceutical Complex
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
WO2001060326A3 (fr) Composition cosmetique ou pharmaceutique contenant une lactone sesquiterpenique
IT9022371A0 (it) Derivati dell'1-arilsolfonil 2-pirrolidone, loro procedimento di preparazione e i nuovi intermedi cosi' ottenuti, il loro impiego come farmaci e le composizioni farmaceutiche che li contengono.
IT1257000B (it) Derivati dell'eserolina ad attivita` anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.
ITMI913511A1 (it) Derivati dell'eserolina ad attivita' anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono